Communicable Diseases

1 Communicable Diseases The whole world was affected by the Covid-19 virus and is currently still trying to fight the pandemic and its impact. Covid 19 is very contagious and can easily spread from one person to another through contaminated respiratory droplets. In a bid to control the spread of the virus and contain its impact, primary, secondary and tertiary prevention measures were utilized, making it an ideal communicable disease for this discussion.

Buy this excellently written paper or order a fresh one from acemyhomework.com

2 Primary prevention strategies are utilized before a disease or injury occurs, to stop its development (Costa, Privitera, Tulli, Toccafondi, 2021). In the Covid-19 pandemic, primary prevention measures mainly aimed at preventing exposures to the virus or infected persons.

Legislations are law enforcements made it possible to ban international travels to countries reporting high numbers of infected people. Also, local and international lockdowns were enforced. Public education and sensitization was also done to emphasize the need to stay home, sanitize hands, wear face masks and observe social distancing and respiratory etiquette (Karamouzian, Johnson & Kerr, 2020).

Secondary prevention measures are done in an already occurring disease to reduce its impact. In covid-19 patients, this was a big challenge as there was no approved treatment for the condition. Patients were treated based on their symptoms and the need for supplemental oxygen.

Supplemental nutrients were also used to boost immunity. Tertiary prevention involves addressing the impacts of an ongoing illness and its lasting effects (Costa, Privitera, Tulli, Toccafondi, 2021). After successful recovery, covid-19 has minimal lasting effect but is paramount for one to prevent reinfection. Primary prevention measures were used to prevent reinfection in discharged patients.

3 References Karamouzian, M., Johnson, C., & Kerr, T. (2020). Public health messaging and harm reduction in the time of COVID-19. The Lancet Psychiatry, 7(5), 390-391.

DOI:https://doi.org/10.1016/S2215-0366(20)30144-9 Costa A.L., Privitera G.P., Tulli G., Toccafondi G. (2021). Infection Prevention and Control. In: Donaldson L., Ricciardi W., Sheridan S., Tartaglia R. (eds) Textbook of Patient Safety and Clinical Risk Management. Springer, Cham. https://doi.org/10.1007/978-3-03059403-9_9